Abstract

A key role in the treatment of herpesviral infections is played by modified nucleosides and their predecessors - acyclovir, its L-valine ester (valaciclovir) and famciclovir (prodrug of penciclovir). The biological activity of compounds of this class is determined by their similarity to natural nucleosides. After phosphorylation by viral thymidine kinase and then cell enzymes to the triphosphate forms, acyclovir and penciclovir inhibit the activity of viral DNA polymerase and synthesis of viral DNA. The increasing role of herpesvirus infections in human infectious pathology, as well as the development of drug resistance in viruses, mainly in patients with immunodeficiencies of various origins, necessitate the search for new compounds possessing anti-herpesvirus activity, using as a biological target not DNA polymerase, but other viral proteins and enzymes, unique or different from cellular proteins, performing similar functions.

Highlights

  • Ключевую роль в лечении герпесвирусных инфекций играют модифицированные нуклеозиды и их предлекарства – ацикловир (АЦВ), его L-валиновый эфир и фамцикловир

  • A key role in the treatment of herpesviral infections is played by modified nucleosides and their predecessors – acyclovir, its L-valine ester and famciclovir

  • The biological activity of compounds of this class is determined by their similarity to natural nucleosides

Read more

Summary

Репликация вирусной ДНК

Аменамевир (АSP2151, UNII-94X46KW4AE; 841301-32-4); (N-(2,6-диметилфенил)-N-[2-[4-(1,2, 4-оксадиазол-3-ил) анилино]-2-оксоэтил]-1,1-ди-оксотиан-4-карбоксамид; C24H26N4O5S, Mr 482,56 BILS 179 BS (UNII-KE7I395I4Q; AC1NUMFT); N-[2-[4-(2-амино-1,3-триазол-4-ил)анилино]-2-оксоэтил]-N[(1S)-1-фенилэтил]пиридин-4-карбоксамид; C25H23N5O2S, Mr 457,55

Ингибиторы герпетической протеазы
Ингибиторы портального белка
Ингибиторы адсорбции и пенетрации вируса в клетку
NH R
Ингибиторы репликации герпесвирусов
Ингибиторы инициации репликации герпесвирусов
Ингибиторы портального белка ВПГ
Ингибиторы биосинтеза полиаминов
Ингибиторы топоизомеразы II
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call